Stock Market News1 month Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study Zacks
INCY stops enrollment in the phase II study of MRGPRX2 in CSU after making certain in vivo preclinical toxicology discoveries.
X2 weeks Incyte’s Late-stage NSCLC Study Meets Primary and Secondary Goals Zacks
X2 weeks EXEL or INCY: Which Is the Better Value Stock Right Now? Zacks
X4 weeks Why Is Incyte (INCY) Up 2.1% Since Last Earnings Report? Zacks
X1 month Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More Zacks
X1 month Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered. Investor's Business Daily
X1 month After-hours movers: Super Micro Computer, Bakkt Holdings, Incyte, and more Investing.com
X2 months BMRN vs. INCY: Which Stock Is the Better Value Option? Zacks
X2 months Incyte (NASDAQ:INCY) Announces Quarterly Earnings Results MarketBeat
X2 months Earnings call: Incyte reports robust growth and pipeline progress Investing.com
X2 months Incyte (NASDAQ:INCY) Raised to “Buy” at Bank of America MarketBeat
X2 months Incyte Breaks Out To 17-Month High As Jakafi Demand Surges Investor's Business Daily
X2 months INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales Zacks
X2 months Here’s What Key Metrics Tell Us About Incyte (INCY) Q3 Earnings Zacks
X2 months Incyte Co. (NASDAQ:INCY) Shares Sold by Mediolanum International Funds Ltd MarketBeat
X2 months Dumont & Blake Investment Advisors LLC Sells 25,529 Shares of Incyte Co. (NASDAQ:INCY) MarketBeat
X2 months Incyte Gears Up to Report Q3 Earnings: Here’s What You Should Know Zacks
X2 months Incyte (INCY) Scheduled to Post Quarterly Earnings on Tuesday MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.